Andrew Kwilasz

Andrew Kwilasz is a seasoned professional with extensive experience in project management, technical research writing, and academia. Currently serving as a Project Manager and Technical Research Writer at BioIntelliSense, Inc. since June 2022, Andrew specializes in creating technical and regulatory documentation for innovative medical devices. In addition to this role, Andrew has been an Adjunct Assistant Professor and Research Associate at the University of Colorado Boulder since June 2013, managing a team to investigate gene therapies and developing new animal models for multiple sclerosis research. Previous roles include consulting on GLP toxicology studies at Xalud Therapeutics, technical writing at Samba Scientific, and adjunct teaching at Regis University. Andrew holds a Ph.D. in Pharmacology and Toxicology from Virginia Commonwealth University, complementing a Bachelor of Arts in Psychology from the University of Wisconsin-Eau Claire.